A personal research platform for identifying high-quality stocks and the investing themes worth your attention, drawing on real-time market data, sentiment analysis, and proprietary screening to surface the names that warrant a closer look.
Fresh from the lab's daily scans — loading…
Composite of eight signals: Buffett Indicator (15%) & Shiller CAPE (15%) are percentile-ranked against their own 10-year history so structurally elevated valuations don't dominate; Fed Model (10%) and the Yield Curve (10%) read stocks-vs-bonds and cycle stage; Credit Spreads (15%, inverted) and Breadth (15%) plus Net New Highs (10%) gauge risk appetite and participation; Fear & Greed (10%) adds short-term sentiment. Updated weekdays around 6:00am ET. Educational only — not investment advice.
Each board's current top pick, refreshed daily. Not financial advice.
The day's trading conditions and what's on the radar.
A market-regime read for momentum traders.
Stocks with abnormal trading activity.
Notable earnings in the next 14 days.
Live tools for scanning, screening, and analyzing the market in real time.
Scans the entire liquid US market for tradeable daily rhythm, ranking a watchlist of day-trade names alongside today's live movers, market chatter, and sector rotation.
Long-term investing thesis combining ETF consensus picks and beaten-down quality stocks. Includes ETF scorecard vs SPY.
Tracks open-market purchases by executives and directors via SEC Form 4. Surfaces cluster buys and C-suite activity.
Daily S&P 500 scan for bull flags, VCPs, BB squeezes, MA crossovers, cup & handles, and gaps. Graded A/B/Watch with cross-references.
A daily deep-dive on the 15 stocks our other dashboards surfaced — verdict, fundamentals, FCF, Graham Number, SEC filings, and the story of why each one made the list.
Deep dives into market trends.
How the lab works, and how its picks have performed.
The Invest Lab runs five proprietary screens each weekday focused on momentum, ETF consensus, deep value, insider conviction, and chart structure. Each codifying a well-known investment style, running it against fresh data so that no single lens is the answer. The goal is to provide signal-rich starting points for your own research and not a "buy this" recommendation.
When the same name appears across multiple dashboards, The Analyst takes over with a fundamental deep-dive that examines P/E, PEG, Free Cash Flow, Graham Number, ROE, and leverage before summarizing the findings with a written verdict.
Below are the receipts so you can see an example of past results. Every top nominee from each scan is logged with a 30-day outcome, and the misses are alongside to keep everything in perspective.
Recent winners are the latest picks to clear their 30-day mark in the green; Hall of fame and Worst misses are the best and worst 30-day outcomes since inception. Each outcome is a point-in-time snapshot taken 30 calendar days after a nominee is flagged — not the stock's current price — so an older entry reflects how the pick did at that horizon, not where it trades today. The headline stats above count all outcomes (wins and losses). Pending nominees are excluded. Past performance is not predictive of future results — educational records of the lab's process, not investment advice.
This is a personal research platform built to support a disciplined, data-driven approach to stock investing. The goal isn't to predict the future but to identify stocks with real momentum, strong market interest, and favorable setups, then do that research faster and more consistently than is possible by hand.
The philosophy is simple, put the focus on green stocks only. Upward-moving tickers with real volume behind them is what the system looks for. There's no short selling and no chasing noise, just systematic screening enriched with sentiment data from professional-grade market feeds and the investing community.
⚠ Nothing on this site is financial advice. All content is for personal educational use only.